Publications in collaboration with researchers from University of Giessen (44)

2024

  1. Correction to: Optical coherence tomography in coronary atherosclerosis assessment and intervention (Nature Reviews Cardiology, (2022), 19, 10, (684-703), 10.1038/s41569-022-00687-9)

    Nature Reviews Cardiology

2023

  1. Morphological characteristics of lesions with thin cap fibroatheroma-a substudy from the COMBINE (OCT-FFR) trial

    European heart journal. Cardiovascular Imaging, Vol. 24, Núm. 5, pp. 687-693

  2. Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: Multilayered cross-talks in the setting of coinfections and comorbidities

    PLoS pathogens, Vol. 19, Núm. 1, pp. e1011063

  3. Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension

    The European respiratory journal, Vol. 61, Núm. 1

2022

  1. Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire

    Annals of the rheumatic diseases, Vol. 81, Núm. 4, pp. 507-515

  2. Emergence of methicillin resistance predates the clinical use of antibiotics

    Nature, Vol. 602, Núm. 7895, pp. 135-141

  3. HIV and Schistosoma Co-Exposure Leads to Exacerbated Pulmonary Endothelial Remodeling and Dysfunction Associated with Altered Cytokine Landscape

    Cells, Vol. 11, Núm. 15

  4. Optical coherence tomography in coronary atherosclerosis assessment and intervention

    Nature Reviews Cardiology, Vol. 19, Núm. 10, pp. 684-703

2021

  1. The burden of systemic sclerosis in Switzerland - the Swiss systemic sclerosis EUSTAR cohort

    Swiss medical weekly, Vol. 151, pp. w20528

2020

  1. EAACI-Leitlinien zur allergen-spezifischen Immuntherapie: Insektengiftallergie

    Allergologie, Vol. 43, Núm. 5, pp. 176-203

  2. Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort

    Rheumatology (United Kingdom), Vol. 59, Núm. 8, pp. 2016-2023

  3. Racial differences in systemic sclerosis disease presentation: A European Scleroderma Trials and Research group study

    Rheumatology (United Kingdom), Vol. 59, Núm. 7, pp. 1684-1694

  4. Usefulness of the updated logistic clinical SYNTAX score after percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the GLOBAL LEADERS trial

    Catheterization and Cardiovascular Interventions, Vol. 96, Núm. 5, pp. E516-E526

2018

  1. Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study

    Arthritis and Rheumatology, Vol. 70, Núm. 11, pp. 1829-1834

  2. Diagnostic performance of in-procedure angiography-derived quantitative flow reserve compared to pressure-derived fractional flow reserve: The FAVOR II Europe-Japan study

    Journal of the American Heart Association, Vol. 7, Núm. 14

  3. Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: The European Scleroderma Observational Study

    Rheumatology (United Kingdom), Vol. 57, Núm. 2, pp. 370-381

  4. Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study

    Annals of the Rheumatic Diseases, Vol. 77, Núm. 4, pp. 563-570

  5. There is a need for new systemic sclerosis subset criteria. A content analytic approach

    Scandinavian Journal of Rheumatology, Vol. 47, Núm. 1, pp. 62-70

2017

  1. The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: Derivation and validation of a preliminarily revised EUSTAR activity index

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 1, pp. 270-276

  2. Treatment outcome in early diffuse cutaneous systemic sclerosis: The European Scleroderma Observational Study (ESOS)

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 7, pp. 1207-1218